Literature DB >> 6277033

Plasma cyclic nucleotide levels in exercise-induced asthma.

J P Hartley, C J Davies, T J Charles, R D Monie, S G Nogrady, M D Winson.   

Abstract

It is known that sympatho-adrenal control of airways is increased in asthma since beta blockade can cause severe bronchoconstriction in asthmatic individuals. It has not been established whether an altered catecholamine response to exercise plays any part in the production of the common symptom of exercise-induced asthma (EIA). We have investigated this indirectly by measuring arterial plasma cyclic nucleotide levels in 10 subjects with EIA and five normal subjects. Cyclic AMP, which in this context reflects beta stimulation, rose significantly by 25.4% in the normal subjects during exercise, while there was no significant change during or after exercise (less than 5%) in the asthmatic subjects. Cyclic GMP rose significantly after exercise in the asthmatic subjects. Six normal subjects repeated the protocol before and after inhalation of salbutamol aerosol, 1600 microgram daily for 18 days. This did not reduce the cAMP response to exercise, and we conclude that the diminished cAMP response of the asthmatic subjects was not caused by their medication. The results may indicate either impaired catecholamine production or endogenous beta receptor hyporesponsiveness in some asthmatic subjects and this may contribute to the development of EIA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6277033      PMCID: PMC471822          DOI: 10.1136/thx.36.11.823

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Comparison of the bronchial response to running and cycling in asthma using an improved definition of the response to work.

Authors:  G J Miller; B H Davies; T J Cole; A Seaton
Journal:  Thorax       Date:  1975-06       Impact factor: 9.139

Review 2.  Clinical studies and applications of cyclic nucleotides.

Authors:  F Murad
Journal:  Adv Cyclic Nucleotide Res       Date:  1973

3.  Sequential estimation of plasma catecholamines in exercise-induced asthma.

Authors:  J Griffiths; F Y Leung; S Grzybowski; M M Chan-Yeung
Journal:  Chest       Date:  1972-11       Impact factor: 9.410

4.  Metabolic changes in exercise-induced asthma.

Authors:  J J Barboriak; A J Sosman; J N Fink; M G Maksud; L H McConnell; L H Hamilton
Journal:  Clin Allergy       Date:  1973-03

5.  Significance of effect of beta blockade on ventilatory function in normal and asthmatic subjects.

Authors:  R S Jones
Journal:  Thorax       Date:  1972-09       Impact factor: 9.139

6.  Effects of beta adrenergic blockade on plasma catecholamines in exercise.

Authors:  M H Irving; B J Britton; W G Wood; C Padgham; M Carruthers
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

7.  Effect of propranolol on ventilatory function.

Authors:  R S McNeill; C G Ingram
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

8.  Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.

Authors:  J H Ball; N I Kaminsky; J G Hardman; A E Broadus; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

9.  Sources of cyclic nucleotides in plasma.

Authors:  R E Wehmann; L Blonde; A L Steiner
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  The effects of glucagon and insulin on adenosine 3':5'-cyclic monophosphate concentrations in an organ culture of mature rat liver.

Authors:  K Siddle; B Kane-Maguire; A K Campbell
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

View more
  2 in total

1.  Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects.

Authors:  A J Fairfax; M Rehahn; D Jones; B O'Malley
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

2.  CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Patrick Oeckl; Petra Steinacker; Stefan Lehnert; Sarah Jesse; Hans A Kretzschmar; Albert C Ludolph; Markus Otto; Boris Ferger
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.